Sanofi to buy US biopharma group Blueprint for up to US$9.5 billion
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in ...
Tag: BioPharma
Medical tourism, biopharma leading the way in China’s healthcare flows to Asean
Patients are flocking to the region in search of good quality, alternative healthcare treatments, while biopharma firms are making forays ...
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding | Entrepreneur
Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.